Portfolio Companies 2026 for Eli Lilly: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Eli Lilly accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $2.3B. The median disclosed raise is $95M, and the largest is NewLimit at $682M, ahead of AdvanCell ($440M) and Iterative Health ($195M).
The names that recur most often on these portfolio cap tables are Eli Lilly (14 companies), Khosla Ventures (3 companies), Abingworth (2 companies), Johnson & Johnson (2 companies), Founders Fund (1 company), Kleiner Perkins (1 company). By latest disclosed round, the market skews Series A (5), Series C (3), Series B (3), Series D (1).
Companies tracked: 14
Disclosed funding total: $2.3B across 14 companies
Median disclosed raise: $95M
Largest raise: NewLimit — $682M
Stage mix: Series A 5 · Series C 3 · Series B 3 · Series D 1
